Skip to main content

Table 5 H. glycines probesets orthologous to dauer-enriched C. elegans genes

From: Divergent evolution of arrested development in the dauer stage of Caenorhabditis elegans and the infective stage of Heterodera glycines

H. glycines probeset EST Contig length C. elegans gene E-value, bit score, % identity (BLASTX*) E-value, bit score, % identity (TBLASTN*) Wormbase descriptor C. elegans gene Cluster InfJ2/parJ2 InfJ2/J3 J3/J4
HgAffx.11262.2.S1_at 1 610 R151.2a 2e-53, 199, 73% 6e-52, 197, 79% Phosphoribosyl pyrophosphate synthetase 1 Up Up  
HgAffx.11331.1.A1_at 1 347 C25B8.3a 3e-26, 107, 85% 9e-25, 107, 85% Peptidase C1A, papain 2 Down Down  
HgAffx.11103.1.S1_at 3 745 C25B8.3a 4e-53, 184, 70% 4e-52, 184, 70% Peptidase C1A, papain 2 Down Down  
HgAffx.11103.1.A1_at 3 745 C25B8.3a 4e-53, 184, 70% 4e-52, 184, 70% Peptidase C1A, papain 2    
HgAffx.11744.1.S1_at 4 656 Y17G7B.17 1e-19, 87, 32% 2e-17, 83, 35% Proliferation-related protein MLF 1    
HgAffx.13580.1.S1_at 2 650 C10C6.5 1e-61, 226, 53% 1e-65, 244, 56% ABC transporter 2    
HgAffx.15051.1.S1_at 16 807 F11G11.1 2e-41, 159, 42% 9e-41, 159, 42% Collagen helix repeat 3   Down  
HgAffx.15051.2.S1_at 6 882 F11G11.2 2e-40, 157, 41% 2e-39, 155, 41% Glutathione S-transferase 4   Down  
HgAffx.15228.1.S1_at 4 1,067 C46F4.2 e-143, 498, 67% e-134, 473, 63% AMP-dependent synthetase and ligase 5 Down Down  
HgAffx.15789.1.S1_at 5 1,217 C46F4.2 5e-40, 155, 36% 6e-39, 155, 36% AMP-dependent synthetase and ligase 2 Down Down  
HgAffx.15789.2.S1_at 3 755 C46F4.2 2e-96, 342, 65% 3e-95, 342, 65% AMP-dependent synthetase and ligase 2 Down Down  
HgAffx.15812.1.S1_at 2 475 C51E3.6 1e-20, 90, 50% 7e-23, 102, 54% Xanthine/uracil/vitamin C permease 2    
HgAffx.15725.1.S1_at 1 476 M110.5b 7e-56, 206, 63% 2e-51, 196, 62% Pleckstrin homology-type 2 Down   
HgAffx.16156.1.S1_at 2 477 C53D6.7 7e-43, 163, 43% 4e-40, 158, 46% Concanavalin A-like lectin/glucanase 2    
HgAffx.16267.1.S1_at 1 291 F11G11.2 3e-22, 94, 52% 6e-21, 94, 52% Glutathione S-transferase 6 Up Up  
HgAffx.17077.1.S1_at 8 1,012 B0361.9 5e-43, 165, 56% 9e-40, 156, 63% N/apple PAN 3 Up Up  
HgAffx.16890.1.S1_at 2 465 K07A3.2a 1e-23, 99, 47% 6e-22, 99, 47% Sterol-sensing 5TM box 3 Up Up  
HgAffx.16917.1.S1_at 2 616 F09G2.3 2e-29, 113, 54% 4e-28, 113, 54% Phosphate transporter 5 Down Down  
HgAffx.17264.1.S1_at 19 1,233 T03E6.7 7e-93, 331, 57% 3e-92, 331, 57% Peptidase C1A, papain 3 Up Up  
HgAffx.17605.1.S1_at 2 636 Y9C9A.16 6e-47, 177, 41% 7e-46, 177, 41% FAD-dep. pyridine oxidoreductase 1   Down  
HgAffx.17530.1.S1_at 2 474 K08H10.4 6e-19, 84, 50% 1e-17, 84, 50% Alpha-isopropylmalate synthase 2 Down   
HgAffx.17668.1.S1_at 1 481 K07C5.5 6e-32, 127, 44% 1e-30, 127, 44% Epoxide hydrolase 2 Down Down  
HgAffx.17855.1.S1_at 6 601 R13A5.3 6e-24, 101, 38% 2e-23, 101, 38% Transthyretin-like 2    
HgAffx.18208.1.S1_at 7 803 K07C11.5 3e-21, 92, 32% 7e-20, 89, 33% Netrin 5 Down Down  
HgAffx.18170.1.S1_at 1 479 F39B3.2 2e-24, 102, 61% 9e-31, 127, 47% Rhodopsin-like GPCR superfamily 5 Down Down  
HgAffx.18607.1.S1_at 9 991 R11F4.1 e-126, 442, 67% e-125, 442, 67% Carbohydrate kinase 2   Up Up
HgAffx.18847.1.S1_at 1 485 Y54G11A.5 8e-70, 251, 81% 2e-69, 251, 81% Catalase 3   Up  
HgAffx.19435.1.S1_at 4 668 Y44F5A.1 2e-33, 133, 38% 1e-30, 127, 37% WD-40 repeat 1 Down Down  
HgAffx.19602.1.S1_at 1 340 C11E4.1 3e-34, 134, 67% 3e-33, 134, 67% Glutathione peroxidase 7 Up Up  
HgAffx.19847.1.S1_at 6 679 W01A11.6 5e-31, 125, 45% 2e-30, 125, 45% Molybdenum biosynthesis protein 6 Up Up  
HgAffx.19874.1.S1_at 1 484 R160.7 7e-36, 140, 58% 2e-34, 140, 58% FYVE zinc finger 2 Down   
HgAffx.19903.1.S1_at 9 630 F45H10.4 4e-28, 115, 42% 2e-27, 155, 42% Unnamed protein 2 Down   
HgAffx.20463.1.S1_at 1 395 F40E10.3 2e-40, 154, 55% 1e-59, 233, 76% Calsequestrin 5 Down Down  
HgAffx.20251.1.S1_at 1 395 C37C3.8b 7e-35, 136, 70% 5e-25, 108, 55% Unnamed protein 6 Up   
HgAffx.20740.1.S1_at 4 574 T28B4.3 4e-31, 125, 50% 4e-22, 97, 40% Transthyretin-like 5   Down  
HgAffx.20171.1.S1_at 2 885 T19B10.3 2e-58, 216, 39% 1e-58, 221, 40% Glycoside hydrolase 2 Down   
HgAffx.20528.1.S1_at 2 653 K09C8.3 2e-28, 116, 33% 2e-19, 90, 31% Peptidase M 3   Up  
HgAffx.20171.1.A1_at 2 885 T19B10.3 2e-58, 216, 39% 1e-58, 221, 40% Glycoside hydrolase 2    
HgAffx.20464.1.S1_at 2 395 E02C12.4 2e-26, 108, 49% 6e-26, 109, 49% Transthyretin-like 5 Down Down  
HgAffx.20474.1.S1_at 5 695 C46F4.2 1e-23, 85, 55% 1e-17, 85, 55% AMP-dependent synthetase and ligase 5    
HgAffx.20842.1.S1_at 15 1,556 C14F11.5 2e-54, 204, 67% 3e-76, 278, 62% Heat shock protein Hsp20 3   Down  
HgAffx.21213.1.S1_at 7 1,329 C10C6.5 4e-32, 129, 36% 4e-31, 129, 36% ABC transporter 7 Up   
HgAffx.22102.1.S1_at 2 556 CC4.2 3e-18, 82, 49% 3e-18, 84, 49% Neuropeptide-like protein, nlp-15 5   Down Down
HgAffx.22266.1.S1_at 3 435 C37H5.3a 3e-33, 131, 47% 9e-32, 131, 47% Alpha/beta hydrolase 1 Down Down  
HgAffx.22554.1.S1_at 5 1,194 H24K24.5 e-109, 387, 48% e-101, 363, 45% Dimethylaniline monooxygenase 3 Up Up  
HgAffx.22270.1.S1_s_at 2 395 T05A7.1 2e-20, 89, 32% 2e-19, 89, 32% Unnamed protein 5 Down Down  
HgAffx.22723.1.S1_at 1 425 F21F3.1 2e-28, 115, 50% 5e-27, 115, 50% Peptidyl-glycine monooxygenase 5 Down Down Down
HgAffx.22678.1.S1_at 11 707 K07E1.1 8e-61, 224, 61% 2e-59, 222, 63% Acireductone dioxygenase 3 Up   
HgAffx.22868.1.S1_at 17 1,373 T03E6.7 e-120, 423, 62% e-120, 423, 62% Peptidase C1A, papain 2    
HgAffx.22801.1.S1_at 6 813 H10D18.2 1e-30, 124, 39% 1e-29, 122, 38% Allergen V5/Tpx-1 related 5 Down Down  
HgAffx.22840.1.S1_at 7 513 T10C6.14 8e-41, 157, 98% 8e-42, 161, 98% Histone H4 5   Down  
HgAffx.22840.2.S1_at 6 501 T10C6.14 1e-41, 159, 97% 4e-41, 159, 97% Histone H4 5   Down  
HgAffx.22798.1.S1_at 27 680 JC8.8 3e-43, 165, 58% 8e-43, 165, 58% Transthyretin-like 1 Down Down  
HgAffx.22879.1.S1_at 2 454 C11E4.2 7e-38, 85, 71% 7e-37, 85, 71% Glutathione peroxidase 7 Up   
HgAffx.22709.1.S1_at 8 1,065 C28H8.6a 8e-85, 304, 58% 3e-84, 304, 58% LIM, zinc-binding 5 Down Down  
HgAffx.23565.1.S1_at 7 549 C11E4.1 1e-57, 213, 62% 1e-56, 212, 63% Glutathione peroxidase 5 Down Down  
HgAffx.23446.1.S1_at 5 876 F07D3.2 2e-19, 87, 51% 6e-18, 83, 38% FMRFamide-related peptide 5   Down Down
HgAffx.23377.1.S1_at 1 485 C33A12.7 7e-46, 173, 57% 7e-45, 173, 57% Metallo-beta-lactamase superfamily 1 Down Down  
HgAffx.24026.1.S1_at 5 541 T07C4.5 2e-23, 99, 46% 6e-23, 99, 46% Transthyretin-like 5 Down Down  
HgAffx.24221.1.S1_at 2 662 H14N18.3 3e-21, 92, 38% 3e-20, 90, 39% Casein 1 Down Down  
HgAffx.250.1.S1_at 7 908 F32A5.4a 3e-35, 139, 34% 4e-34, 137, 39% Proteinase inhibitor I33, aspin 1 Down   
HgAffx.2812.1.S1_at 3 500 R11A8.4 2e-24, 102, 42% 2e-22, 100, 49% Silent information regulator protein 2 2 Down Down  
HgAffx.2812.1.A1_at 3 500 R11A8.4 2e-24, 102, 42% 2e-22, 100, 49% Silent information regulator protein 2 1    
HgAffx.24343.1.S1_at 8 657 B0334.1 5e-28, 115, 46% 6e-31, 126, 49% Transthyretin-like 7    
HgAffx.2920.1.S1_at 3 578 T10C6.14 3e-19, 85, 52% 1e-21, 94, 53% Histone H4 3 Up Up  
HgAffx.2920.1.A1_at 3 578 T10C6.14 3e-19, 85, 52% 1e-21, 94, 53% Histone H4 3   Up  
HgAffx.2888.1.S1_at 2 473 T25B9.7 7e-25, 103, 35% 2e-23, 103, 35% UDP-glucuronosyl/glucosyltransferase 3   Down  
HgAffx.2888.1.A1_at 2 473 T25B9.7 7e-25, 103, 35% 2e-23, 103, 35% UDP-glucuronosyl/glucosyltransferase 4   Down  
HgAffx.4596.1.S1_at 1 573 C54D10.10 1e-18, 84, 43% 7e-18, 84, 43% Proteinase inhibitor I2 3 Up Up  
HgAffx.4485.1.S1_at 1 623 ZK945.1 5e-45, 171, 45% 8e-44, 171, 45% Penicillin-binding protein 3 Up Up  
HgAffx.5769.1.S1_at 1 620 K10B3.6a 2e-20, 89, 32% 5e-19, 89, 32% Phosphodiesterase 3    
HgAffx.6540.1.S1_at 2 655 ZK945.1 4e-57, 211, 58% 5e-56, 211, 58% Penicillin-binding protein 3 Up Up  
HgAffx.8976.1.S1_at 2 694 T24D8.5 6e-18, 81, 70% 2e-17, 81, 70% Neuropeptide-like protein, nlp-2 5 Down Down  
HgAffx.9380.1.S1_at 2 756 Y54G11A.5 2e-84, 302, 60% 9e-86, 310, 62% Catalase 1    
  1. *BLASTX of H. glycines nucleotide probesets against C. elegans proteins and TBLASTN of C. elegans proteins against H. glycines nucleotide probesets. Differential expression (FDR 5%) where indicated and direction of expression change relative to infective J2. Full-length sequence.